deltatrials
Terminated PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT02614703

Acetic Acid Chromoendoscopy in Barrett's Esophagus Surveillance

Acetic Acid Chromoendoscopy in Barrett's Esophagus Surveillance is Superior to the Standardized Random Biopsy Protocol in Detecting Neoplasia: A Prospective Randomized Study

Sponsor: DHR Health Institute for Research and Development

Conditions Barrett's Esophagus
Interventions Chromoendoscopy using Acetic Acid 2.5% Standard random esophageal biopsies
Updated 11 times since 2017 Last updated: Aug 25, 2021 Started: Mar 10, 2017 Primary completion: Jul 30, 2018 Completion: Jul 30, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Sample was under-powered

Other Barrett's Esophagus trials with similar outcome

Browse all Barrett's Esophagus trials

Listed as NCT02614703, this PHASE2/PHASE3 trial focuses on Barrett's Esophagus and remains terminated or withdrawn. Sponsored by DHR Health Institute for Research and Development, it has been updated 11 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotNot Yet Recruiting~Feb 2017 – ~Mar 2017 · 28 days · monthly snapshotNot Yet Recruiting~Mar 2017 – ~Apr 2017 · 31 days · monthly snapshotNot Yet Recruiting~Apr 2017 – ~Jun 2018 · 14 months · monthly snapshotRecruiting~Jun 2018 – ~Apr 2019 · 10 months · monthly snapshotRecruiting~Apr 2019 – ~Sep 2019 · 5 months · monthly snapshotUnknown Status~Sep 2019 – ~Jan 2021 · 16 months · monthly snapshotTerminated~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshotTerminated~Sep 2021 – ~Jul 2024 · 34 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  3. Sep 2021 — Jul 2024 [monthly]

    Terminated PHASE2_PHASE3

  4. Jan 2021 — Sep 2021 [monthly]

    Terminated PHASE2_PHASE3

  5. Sep 2019 — Jan 2021 [monthly]

    Terminated PHASE2_PHASE3

    Status: Unknown Status → Terminated

▶ Show 6 earlier versions

  1. Apr 2019 — Sep 2019 [monthly]

    Unknown Status PHASE2_PHASE3

    Status: Recruiting → Unknown Status

  2. Jun 2018 — Apr 2019 [monthly]

    Recruiting PHASE2_PHASE3

  3. Apr 2017 — Jun 2018 [monthly]

    Recruiting PHASE2_PHASE3

    Status: Not Yet Recruiting → Recruiting

  4. Mar 2017 — Apr 2017 [monthly]

    Not Yet Recruiting PHASE2_PHASE3

  5. Feb 2017 — Mar 2017 [monthly]

    Not Yet Recruiting PHASE2_PHASE3

  6. Jan 2017 — Feb 2017 [monthly]

    Not Yet Recruiting PHASE2_PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • DHR Health Institute for Research and Development
Data source: DHR Health Institute for Research and Development

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations